ホスホロアミダイトの世界市場

ホスホロアミダイトの世界市場は2030年までに16億米ドルに達する

2024年に11億米ドルと推定されたホスホロアミダイトの世界市場は、2030年には16億米ドルに達し、分析期間2024-2030年のCAGRは6.3%で成長すると予測されます。本レポートで分析したセグメントの1つであるDNAホスホラミダイトは、CAGR 7.4%を記録し、分析期間終了時には6億6,270万米ドルに達すると予測されています。RNAホスホラミダイトセグメントの成長率は、分析期間でCAGR 4.4%と推定されます。

米国市場は3億650万米ドルと推定、中国はCAGR 10.1％で成長予測

米国のホスホロアミダイト市場は、2024年に3億650万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR10.1％を追いかけ、2030年までに3億3,600万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.0％と6.2％と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

ホスホロアミダイト市場：主要動向と促進要因のまとめ

なぜホスホロアミダイトは核酸合成において重要なコンポーネントなのか？

ホスホロアミダイト化学は、DNA、RNA、オリゴヌクレオチドの合成において基本的な役割を果たし、分子生物学、製薬研究、遺伝子工学において重要な試薬となっています。ホスホルアミダイトは固相合成に用いられる反応性中間体であり、PCR、遺伝子編集、アンチセンス療法、siRNA（低分子干渉RNA）、CRISPRベースの遺伝子編集技術用の合成オリゴヌクレオチドの製造に広く採用されている方法です。

合成生物学、遺伝子治療、個別化医療が普及するにつれ、高純度ホスホルアミダイトの需要が急増しています。製薬会社、バイオテクノロジー企業、学術研究機関は、診断アッセイ、ワクチン開発、標的ドラッグデリバリーシステムに不可欠なカスタムDNAおよびRNA配列を製造するために、ホスホロアミダイト化学に依存しています。さらに、次世代シーケンシング（NGS）とRNA治療薬がホスホラミダイトの応用範囲を拡大し、市場の成長をさらに促進しています。

ホスホロアミダイト市場を牽引する主要動向は？

ホスホロアミダイト市場は、遺伝子医療、合成生物学、核酸ベースの治療薬の進歩に後押しされ、急速に拡大しています。いくつかの重要な動向が業界の成長軌道を形成しています。

最も重要な動向の一つは、核酸ベースの治療薬、特にmRNAワクチン、アンチセンス・オリゴヌクレオチド（ASOs）、small interfering RNA（siRNA）療法に対する需要の増加です。mRNAベースのCOVID-19ワクチンの成功は合成RNAの可能性を示し、大規模RNA生産に使用される修飾および非修飾ホスホラミダイトの需要を押し上げました。mRNAベースのがん免疫療法、個別化ワクチン、希少疾患治療が勢いを増す中、ホスホロアミダイトメーカーは業界の高まるニーズに応えるべく生産能力を拡大しています。

もう一つの重要な動向は、CRISPRと遺伝子編集技術の台頭です。CRISPRベースのシステムは、ホスホロアミダイトのケミストリーを用いて合成される合成ガイドRNA（gRNA）分子に依存しています。遺伝子編集研究、細胞・遺伝子治療アプリケーション、精密医療の拡大により、治療アプリケーション用に設計された高純度の特殊ホスホラミダイトの需要が高まっています。

次世代シーケンシング（NGS）および分子診断分野も、ホスホロアミダイト消費の主要な促進要因です。NGSプラットフォームでは、シーケンスのプライマーやアダプターとして合成オリゴヌクレオチドを使用するため、安定性と効率を高めた修飾ホスホロアミダイトの大量生産が必要となります。リキッドバイオプシー診断、パーソナライズドゲノミクス、病原体検出アッセイの採用が進むにつれ、臨床や研究の現場では、ホスホロアミダイトベースの試薬が不可欠になってきています。

さらに、化学修飾や特殊なホスホルアミダイトが応用の可能性を広げています。蛍光標識ホスホルアミダイト、バイオコンジュゲート誘導体、ロックド核酸（LNA）ホスホルアミダイトは、高度な分子プローブ、リアルタイムPCRアッセイ、RNAベースの治療薬の開発を可能にしています。ハイスループットスクリーニング（HTS）、創薬、ナノ粒子ベースのドラッグデリバリーシステム向けのホスホロアミダイト試薬のカスタマイズは、市場のイノベーションをさらに促進しています。

最終用途はホスホロアミダイト市場にどのような影響を与えているか？

ホスホロアミダイトの多様な用途は、医薬品、バイオテクノロジー、分子診断、合成生物学など、さまざまな業界に及んでいます。各分野で独自の要求があり、特殊なホスホロアミダイト試薬の開発・生産に影響を与えています。

製薬業界とバイオテクノロジー業界は、特にオリゴヌクレオチドベースの医薬品開発において、ホスホラミダイトの最大の消費者です。アンチセンスオリゴヌクレオチド（ASO）、siRNA医薬品、アプタマーベースの治療薬、mRNAワクチンなどを開発する企業は、精密なオリゴヌクレオチド合成にホスホロアミダイト化学を利用しています。FDAがパティシラン（遺伝性ATTRアミロイドーシス）やヌシネルセン（脊髄性筋萎縮症）などの複数のRNAベースの治療薬を承認したことにより、ホスホロアミダイトベースの医薬品開発への投資が加速しています。

分子診断学やゲノミクスの分野では、ホスホロアミダイトベースのオリゴヌクレオチドは、PCRプライマー、シークエンスプローブ、マイクロアレイ、遺伝子発現アッセイに不可欠な構成要素となっています。高忠実度の修飾ヌクレオチドに対する需要は、ポイントオブケア診断、感染症スクリーニング、がんバイオマーカー検出の台頭とともに高まっています。リキッドバイオプシー技術や家庭用遺伝子検査キットが主流になるにつれて、ホスホロアミダイトサプライヤーは多様なアプリケーションのニーズに対応するために製品を拡大しています。

合成生物学分野もホスホロアミダイトの急成長市場です。科学者たちは、遺伝子組み換え生物（GMO）、生物工学的酵素、産業用・環境用の合成代謝経路を作るために、カスタムDNAやRNA配列をエンジニアリングしています。ホスホロアミダイトに基づくDNA合成が農業バイオテクノロジー、バイオ燃料生産、酵素工学に統合されることで、市場に新たな成長機会がもたらされています。

ホスホロアミダイト市場の成長を促進する要因は？

ホスホロアミダイト市場の成長は、遺伝子医学の進歩、核酸ベースの医薬品承認の増加、合成生物学アプリケーションの拡大など、複数の要因によって牽引されています。

主な成長要因の1つは、RNAベースの治療薬やワクチンに対する需要の高まりです。mRNAワクチン・プラットフォームの成功は、RNAが実行可能な治療手段であることを証明し、製薬会社にRNA干渉（RNAi）療法、自己増幅RNA（saRNA）ワクチン、円形RNA（circRNA）技術への投資を促しました。このため、RNA合成、化学修飾、ナノ粒子製剤用に調整されたホスホロアミダイト試薬の需要が増加しています。

DNA/RNA自動合成機の技術的進歩も市場成長を後押ししています。高スループットオリゴヌクレオチド合成機の導入により、カスタム核酸製造の効率が向上し、研究者は精密な修飾を施したより長く複雑なRNA分子を生成できるようになりました。ホスホルアミダイトのメーカーは、ハイスループット合成アプリケーションをサポートするため、試薬の純度、安定性、保存性の向上に注力しています。

さらに、核酸ベースの医薬品の規制当局による承認が拡大していることも、市場の需要を強めています。FDAやEMAなどの規制機関は、複数のアンチセンスオリゴヌクレオチド、siRNAベースの医薬品、遺伝子編集療法を承認しており、オリゴヌクレオチドベースの医薬品の商業的可能性を強化しています。RNA治療薬や遺伝子治療の分野に参入する企業が増えるにつれて、高品質のホスホロアミダイト試薬の需要が急増すると予想されます。

持続可能性とグリーンケミストリーへの取り組みもホスホロアミダイトの生産に影響を与えています。従来のホスホロアミダイトベースの化学合成に代わる環境に優しい技術として、無溶媒DNA合成技術や酵素DNA合成技術が台頭してきています。これらの技術はまだ初期段階にあるが、企業は業界全体の環境目標に沿うため、より持続可能な試薬処方やより環境に優しい合成方法に投資しています。

セグメント

タイプ（DNAホスホラミダイト、RNAホスホラミダイト、標識ホスホラミダイト、修飾ホスホラミダイト、その他）、用途（創薬開発、診断開発、その他）、最終用途（製薬・バイオテクノロジー企業、学術・研究機関、その他）

調査対象企業の例

• ATDBio Ltd.
• BioAutomation Corporation
• BIONEER Corporation
• Bio-Synthesis Inc.
• ChemGenes Corporation
• Expedeon AG
• Genscript Biotech Corporation
• Hongene Biotech Corporation
• Honya Biotech
• Integrated DNA Technologies, Inc.
• LGC Biosearch Technologies
• Link Technologies Ltd.
• Lumiprobe Corporation
• Merck KGaA
• PolyOrg, Inc.
• QIAGEN N.V.
• Sigma-Aldrich（MilliporeSigma）
• Thermo Fisher Scientific Inc.
• TriLink BioTechnologies
• Wuxi Donglin Sci & Tech Dev. Co.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Phosphoramidite Market to Reach US$1.6 Billion by 2030

The global market for Phosphoramidite estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. DNA Phosphoramidites, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$662.7 Million by the end of the analysis period. Growth in the RNA Phosphoramidites segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$306.5 Million While China is Forecast to Grow at 10.1% CAGR

The Phosphoramidite market in the U.S. is estimated at US$306.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$336.0 Million by the year 2030 trailing a CAGR of 10.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Phosphoramidite Market: Key Trends & Drivers Summarized

Why Is Phosphoramidite a Crucial Component in Nucleic Acid Synthesis?

Phosphoramidite chemistry plays a fundamental role in the synthesis of DNA, RNA, and oligonucleotides, making it a critical reagent in molecular biology, pharmaceutical research, and genetic engineering. Phosphoramidites are reactive intermediates used in solid-phase synthesis, a method widely employed in the production of synthetic oligonucleotides for PCR, gene editing, antisense therapies, siRNA (small interfering RNA), and CRISPR-based gene editing technologies.

As synthetic biology, gene therapies, and personalized medicine gain traction, demand for high-purity phosphoramidites has surged. Pharmaceutical companies, biotech firms, and academic research institutions rely on phosphoramidite chemistry to produce custom DNA and RNA sequences, which are essential for diagnostic assays, vaccine development, and targeted drug delivery systems. Additionally, next-generation sequencing (NGS) and RNA therapeutics have expanded the application scope of phosphoramidites, further driving market growth.

What Are the Key Trends Driving the Phosphoramidite Market?

The phosphoramidite market is undergoing rapid expansion, fueled by advancements in genetic medicine, synthetic biology, and nucleic acid-based therapeutics. Several key trends are shaping the industry's growth trajectory.

One of the most significant trends is the increasing demand for nucleic acid-based therapeutics, particularly mRNA vaccines, antisense oligonucleotides (ASOs), and small interfering RNA (siRNA) therapies. The success of mRNA-based COVID-19 vaccines has demonstrated the potential of synthetic RNA, boosting demand for modified and unmodified phosphoramidites used in large-scale RNA production. As mRNA-based cancer immunotherapies, personalized vaccines, and rare disease treatments gain momentum, phosphoramidite manufacturers are scaling up production capacity to meet growing industry needs.

Another important trend is the rise of CRISPR and gene editing technologies. CRISPR-based systems rely on synthetic guide RNA (gRNA) molecules, which are synthesized using phosphoramidite chemistry. The expansion of gene editing research, cell and gene therapy applications, and precision medicine is driving demand for high-purity, specialty phosphoramidites designed for therapeutic applications.

The next-generation sequencing (NGS) and molecular diagnostics sectors are also key drivers of phosphoramidite consumption. NGS platforms use synthetic oligonucleotides as sequencing primers and adapters, necessitating the large-scale production of modified phosphoramidites with enhanced stability and efficiency. With the growing adoption of liquid biopsy diagnostics, personalized genomics, and pathogen detection assays, phosphoramidite-based reagents are becoming indispensable in clinical and research settings.

Additionally, chemical modifications and specialty phosphoramidites are expanding application possibilities. Fluorescent-labeled phosphoramidites, bioconjugated derivatives, and locked nucleic acid (LNA) phosphoramidites are enabling the development of advanced molecular probes, real-time PCR assays, and RNA-based therapeutics. The customization of phosphoramidite reagents for high-throughput screening (HTS), drug discovery, and nanoparticle-based drug delivery systems is further driving market innovation.

How Are End-Use Applications Influencing the Phosphoramidite Market?

The diverse applications of phosphoramidites span multiple industries, including pharmaceuticals, biotechnology, molecular diagnostics, and synthetic biology. Each sector presents unique requirements, influencing the development and production of specialized phosphoramidite reagents.

The pharmaceutical and biotech industries represent the largest consumers of phosphoramidites, particularly for oligonucleotide-based drug development. Companies developing antisense oligonucleotides (ASOs), siRNA drugs, aptamer-based therapeutics, and mRNA vaccines rely on phosphoramidite chemistry for precise oligonucleotide synthesis. The FDA’s approval of multiple RNA-based therapies, such as patisiran (for hereditary ATTR amyloidosis) and nusinersen (for spinal muscular atrophy), has accelerated investments in phosphoramidite-based drug development.

In molecular diagnostics and genomics, phosphoramidite-based oligonucleotides are essential components of PCR primers, sequencing probes, microarrays, and gene expression assays. The demand for high-fidelity, modified nucleotides has increased with the rise of point-of-care diagnostics, infectious disease screening, and cancer biomarker detection. As liquid biopsy technologies and at-home genetic testing kits become mainstream, phosphoramidite suppliers are expanding their offerings to meet diverse application needs.

The synthetic biology sector is another rapidly growing market for phosphoramidites. Scientists are engineering custom DNA and RNA sequences to create genetically modified organisms (GMOs), bioengineered enzymes, and synthetic metabolic pathways for industrial and environmental applications. The integration of phosphoramidite-based DNA synthesis into agricultural biotechnology, biofuel production, and enzyme engineering is opening new growth opportunities for the market.

What Factors Are Driving the Growth of the Phosphoramidite Market?

The growth in the phosphoramidite market is driven by multiple factors, including advancements in genetic medicine, increasing nucleic acid-based drug approvals, and the expansion of synthetic biology applications.

One of the primary growth drivers is the rising demand for RNA-based therapeutics and vaccines. The success of mRNA vaccine platforms has validated RNA as a viable therapeutic modality, encouraging pharmaceutical companies to invest in RNA interference (RNAi) therapies, self-amplifying RNA (saRNA) vaccines, and circular RNA (circRNA) technologies. This has led to increased demand for phosphoramidite reagents tailored for RNA synthesis, chemical modifications, and nanoparticle formulation.

Technological advancements in automated DNA/RNA synthesizers are also propelling market growth. The introduction of high-throughput oligonucleotide synthesizers has improved the efficiency of custom nucleic acid production, enabling researchers to generate longer, more complex RNA molecules with precise modifications. Manufacturers of phosphoramidites are focusing on improving reagent purity, stability, and shelf life to support high-throughput synthesis applications.

Additionally, the expanding regulatory approval of nucleic acid-based drugs is strengthening market demand. Regulatory agencies such as the FDA and EMA have approved multiple antisense oligonucleotides, siRNA-based drugs, and gene-editing therapies, reinforcing the commercial viability of oligonucleotide-based pharmaceuticals. As more companies enter the RNA therapeutics and gene therapy space, the demand for high-quality phosphoramidite reagents is expected to surge.

Sustainability and green chemistry initiatives are also influencing phosphoramidite production. Solvent-free and enzymatic DNA synthesis technologies are emerging as eco-friendly alternatives to traditional phosphoramidite-based chemical synthesis. While these technologies are still in their early stages, companies are investing in more sustainable reagent formulations and greener synthesis methods to align with industry-wide environmental goals.

SCOPE OF STUDY:

The report analyzes the Phosphoramidite market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Others); Application (Drug Discovery & Development, Diagnostics Development, Others); End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

• ATDBio Ltd.
• BioAutomation Corporation
• BIONEER Corporation
• Bio-Synthesis Inc.
• ChemGenes Corporation
• Expedeon AG
• Genscript Biotech Corporation
• Hongene Biotech Corporation
• Honya Biotech
• Integrated DNA Technologies, Inc.
• LGC Biosearch Technologies
• Link Technologies Ltd.
• Lumiprobe Corporation
• Merck KGaA
• PolyOrg, Inc.
• QIAGEN N.V.
• Sigma-Aldrich (MilliporeSigma)
• Thermo Fisher Scientific Inc.
• TriLink BioTechnologies
• Wuxi Donglin Sci & Tech Dev. Co.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Phosphoramidite - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Oligonucleotide Therapeutics and mRNA Technologies Spurs Use of High-Purity Phosphoramidites
  • Expansion of Nucleic Acid-Based Drug Development Strengthens Business Case for Custom and Modified Phosphoramidites
  • Growth in Gene Editing and CRISPR Applications Drives Need for High-Fidelity Phosphoramidite Synthesis
  • Increased Use of DNA and RNA Probes in Diagnostics and Research Fuels Market for Functionalized Phosphoramidites
  • Commercialization of RNA Vaccines and Antisense Therapies Accelerates Demand for Large-Scale Phosphoramidite Manufacturing
  • Advancements in Solid-Phase Oligonucleotide Synthesis Technology Enhance Efficiency and Yield of Phosphoramidite Reagents
  • Emergence of Synthetic Biology and DNA Data Storage Expands Use Cases for Specialty Phosphoramidites
  • Growing Investment in Personalized Medicine and Targeted Therapies Supports Custom Nucleotide Synthesis Markets
  • Automation and Miniaturization in Oligo Synthesis Platforms Propel Demand for High-Throughput Phosphoramidite Reagents
  • Rising R&D in Aptamers, siRNA, and miRNA-Based Therapeutics Generates Demand for Modified Nucleotide Building Blocks
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Phosphoramidite Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Phosphoramidite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Phosphoramidite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Phosphoramidite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for DNA Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for DNA Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for DNA Phosphoramidites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for RNA Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for RNA Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for RNA Phosphoramidites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Labeled Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Labeled Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Labeled Phosphoramidites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Modifier Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Modifier Phosphoramidites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Modifier Phosphoramidites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostics Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Diagnostics Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Diagnostics Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Phosphoramidite by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Phosphoramidite by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Phosphoramidite by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Phosphoramidite by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Phosphoramidite by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Phosphoramidite by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Phosphoramidite by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Phosphoramidite by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Phosphoramidite by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Phosphoramidite by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Phosphoramidite by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Phosphoramidite Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Phosphoramidite by Type - DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Phosphoramidite by Type - Percentage Breakdown of Value Sales for DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites and Other Types for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Phosphoramidite by End-Use - Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Phosphoramidite by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Other End-Uses and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Phosphoramidite by Application - Drug Discovery & Development, Diagnostics Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Phosphoramidite by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development, Diagnostics Development and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION